医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Oxea Announces Price Increase for Carboxylic Acids

2013年01月05日 AM12:25
このエントリーをはてなブックマークに追加


 

DALLAS

Oxea will increase list and off-list prices on the product below effective January 15, 2013, or as contracts allow.

Product   North America   Asia, Middle East
    USD/lb USD/mt
2-Ethylhexanoic acid 0,03 100

Oxea is a global manufacturer of oxo intermediates and oxo derivatives, such as alcohols, polyols, carboxylic acids, specialty esters, and amines. These products are used for the production of high-quality coatings, lubricants, cosmetics and pharmaceutical products, flavorings and fragrances, printing inks and plastics. In 2011, Oxea generated revenue of about EUR 1.5 billion with its 1,365 employees in Europe, the Americas and Asia.

For more information, visit www.oxea-chemicals.com.

CONTACT

Commercial contact:
OXEA Corporation, 1505 West LBJ Freeway,
Dallas, TX, 75234, USA
Cristóbal Ascencio, Vice President
Oxo-Derivatives
Phone +1 972-481-2700, fax +1 972-481-6023
info@oxea-chemicals.com,
www.oxea-chemicals.com
or
Press
contact:

OXEA GmbH, Otto-Roelen-Strasse 3, D-46147 Oberhausen
Birgit
Reichel, phone +49 (0) 208-693-3112, fax +49 (0) 208-693-3101
birgit.reichel@oxea-chemicals.com,
www.oxea-chemicals.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Code Corporation Expands Into Australian Healthcare Market, Signs HPA as New Channel Partner
  • Asahi Kasei and Nara Medical University Confirm 226 nm UVC LED Efficacy Against SARS-CoV-2 and Verify Reduced Effect on Animal Skin Cells
  • HiFiBiO Therapeutics Closes $75 Million Series D Financing to Accelerate Pipeline With Two Lead Immuno-Oncology Programs and Validate Its DIS™ Approach in the Clinic
  • Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research
  • アジェンディアのマンマプリント検査、NSABP B-42試験で長期内分泌療法の利点を予測する能力を初めて示す